Effect of the clinical course of acute on chronic liver failure prior to liver transplantation on post-transplant survival.
We evaluated whether the clinical course of acute on chronic liver failure (ACLF) between time of listing and liver transplantation (LT) affects one-year post-transplant survival. We identified patients from the UNOS database who were transplanted within 28 days of listing, and categorized them by ACLF grade at waitlist registration and LT, per the EASL-CLIF definition. 3,636 patients listed with ACLF-3 underwent LT within 28-days. Among those transplanted, 892 (24.5%) recovered to no ACLF or ACLF grade 1 or 2 (ACLF 0-2) and 2,744 (75.5%) had ACLF-3 at transplantation. One-year survival was 82.0% among those transplanted with ACLF-3 versus 88.2% among those improving to ACLF 0-2 (p<0.001). Conversely, the survival of patients listed with ACLF 0-2 who progressed to ACLF-3 at LT (n=2,265) was significantly lower than that of recipients who remained at ACLF 0-2 (n=17,631) at the time of LT (83.8% vs 90.2%, p<0.001). Cox modeling demonstrated that recovery of ACLF-3 to ACLF 0-2 at LT was associated with reduced one-year mortality after transplantation (HR=0.65, 95% CI 0.53-0.78). Improvement in circulatory (HR=0.57, 95% CI 0.43-0.75) and brain failure (HR=0.76, 95% CI 0.60-0.97) and stopping mechanical ventilation (HR=0.55, 95% CI 0.42-0.71) were also associated with reduced post-LT mortality. Age above 60 years was a risk factor for post-transplant mortality (HR=1.68, 95% CI 1.31-2.18), but one-year survival increased from 74.9% to 82.7% among those older than 60 years who improved from ACLF-3 to ACLF 0-2 (p<0.001). Improvement of ACLF-3 at listing to ACLF 0-2 at transplantation enhances post-LT survival, particularly in recipients who are older than age 60, who were removed from the mechanical ventilator, or who recovered from circulatory or brain failure. Liver transplantation (LT) for patients with acute on chronic liver failure grade 3 (ACLF-3) significantly improves survival, but 1-year survival probability after LT remains lower than the expected outcomes for transplant centers. Our study reveals that among patients transplanted within 28 days of waitlist registration, improvement of ACLF-3 at listing to a lower grade of ACLF at transplantation significantly enhances post-transplant survival, even among patients above 60 years. Subgroup analysis further demonstrates that improvement in circulatory failure, brain failure, or removal from mechanical ventilation has the strongest impact on post-transplant survival.